Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:40 PM
Ignite Modification Date:
2025-12-24 @ 1:40 PM
NCT ID:
NCT07187895
Eligibility Criteria:
Inclusion Criteria:
* 1.Male or female participants aged 18 years or older. 2.Suspected or known stable coronary artery disease with related symptoms and stable condition, and having at least one coronary artery disease risk factor, including: hypertension, hyperlipidemia, diabetes, obesity, alcohol abuse, smoking, family history of coronary artery disease, postmenopausal status in women, or advanced age.
3.Underwent coronary CTA within the past 6 months showing 30%-90% stenosis, or indicating mild to moderate-to-severe stenosis.
4.Able to communicate effectively with the investigators, understand and comply with the clinical study requirements, voluntarily participate in the study, and provide written informed consent.
Exclusion Criteria:
* 1\. Patients with a history of percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG).
2.Patients with a prior diagnosis of myocardial infarction, congenital heart disease, cardiomyopathy, myocarditis, or other cardiac diseases.
3.Patients known to have severe allergic reactions to alcohol. 4.Patients known to have an allergy or other contraindications to adenosine. 5.Patients known to be allergic to iodinated contrast agents. 6.Individuals with significant occupational exposure to ionizing radiation within the past 10 years (e.g., exceeding 50 mSv/year), or exposure to radioactive substances or ionizing radiation for therapeutic or research purposes.
7.Men and women of childbearing potential who do not plan to use effective contraception during the study and for 6 months after study completion (effective methods include sterilization, intrauterine hormonal devices, condoms, contraceptive pills/agents, abstinence, or partner vasectomy/tubal ligation).
8.Pregnant or lactating women. 9.Patients with claustrophobia, bipolar disorder, other psychiatric disorders, or poor compliance.
10.Patients who participated in another investigational drug clinical study within 30 days prior to enrollment or plan to do so during follow-up.
11.Any other condition that, in the opinion of the investigators, makes the patient unsuitable for participation.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07187895
Study Brief:
Protocol Section:
NCT07187895